[Therapy in metastasizing ovarian cancer--survival rate correlated with histological and cytological grading as prognostic factors].
The histologic grading especially of the modified Broders'-Grading is a suitable prognostic factor in Ovarian Carcinoma. Our investigations show this to be especially true after failure with first line chemotherapeutic agents. These morphologic gradings should especially be used for the selection for high risk patients and for the treatment planning in ovarian carcinoma.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology; D010347:Patient Care Planning; D011379:Prognosis
D000970:Antineoplastic Agents
Therapie beim metastasierenden Ovarialkarzinom--Uberlebensrate in Abhängigkeit vom histologischen und zytologischen Grading als prognostischen Faktoren.